×
Back to Agenda
Closing Remarks
Speaker(s)
Robert A. Lionberger, PhD
Director, Office of Research and Standards, Office of Generic Drugs, CDER, FDA, United States
Combination Drug Products and Generic Drug Science
Have an account?